Cargando…
Tolerogenic IDO1(+)CD83(−) Langerhans Cells in Sentinel Lymph Nodes of Patients with Melanoma
Langerhans cells (LCs) are crucial regulators of anti-cancer immune responses. Cancer, however, can alter DCs functions leading to tolerance. The enzyme indoleamine 2,3-dioxygenase (IDO1) plays a crucial role in this process. In sentinel lymph nodes (SLNs) of patients with melanoma, LCs show phenoty...
Autores principales: | Gerlini, Gianni, Di Gennaro, Paola, Pimpinelli, Nicola, Sestini, Serena, Borgognoni, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998685/ https://www.ncbi.nlm.nih.gov/pubmed/35408802 http://dx.doi.org/10.3390/ijms23073441 |
Ejemplares similares
-
Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
por: Gerlini, Gianni, et al.
Publicado: (2012) -
Missing sentinel lymph node in cutaneous melanoma
por: Dellavedova, Luca, et al.
Publicado: (2015) -
The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N = 2,086)
por: Tropea, Saveria, et al.
Publicado: (2022) -
Survival and the Sentinel Lymph Node in Melanoma
por: Faries, Mark
Publicado: (2009) -
Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
por: Montagnani, Valentina, et al.
Publicado: (2015)